share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰制药 | 4：持股变动声明-高管 Bozic Carmen
美股sec公告 ·  06/28 16:09
Moomoo AI 已提取核心信息
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 26, 2024. The transaction was executed at a price of $471.72 per share, resulting in a total sale value of $1,075,521.60. Following the sale, Bozic's direct holdings in the company amount to 30,099 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 26, 2024. The transaction was executed at a price of $471.72 per share, resulting in a total sale value of $1,075,521.60. Following the sale, Bozic's direct holdings in the company amount to 30,099 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
2024年6月26日，Vertex Pharmaceuticals Inc.(VRTX)的执行副总裁兼首席营销官Carmen Bozic出售了2280股普通股。成交价为471.72美元/股，总交易金额为1,075,521.60美元。出售后，Bozic在该公司的直接持股为30,099股普通股。该交易是通过公开市场交易进行的，正如该公司最新的提交文件所述。
2024年6月26日，Vertex Pharmaceuticals Inc.(VRTX)的执行副总裁兼首席营销官Carmen Bozic出售了2280股普通股。成交价为471.72美元/股，总交易金额为1,075,521.60美元。出售后，Bozic在该公司的直接持股为30,099股普通股。该交易是通过公开市场交易进行的，正如该公司最新的提交文件所述。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息